Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma
Sergey I. Nikolaev(University of Geneva), Donata Rimoldi(University of Lausanne), Christian Iseli(Ludwig Cancer Research), Armand Valsesia(Ludwig Cancer Research), Daniel Robyr(University of Geneva), Corinne Gehrig(University of Geneva), Keith Harshman, Michel Guipponi(University of Geneva), Olesya V. Bukach(University of Geneva), Vincent Zoete(SIB Swiss Institute of Bioinformatics), Olivier Michielin(University Hospital of Lausanne), Katja Muehlethaler(Ludwig Cancer Research), Daniel E. Speiser(Ludwig Cancer Research), J. Beckmann(University of Lausanne), Ioannis Xénarios(SIB Swiss Institute of Bioinformatics), Thanos D. Halazonetis(University of Geneva), C. Victor Jongeneel(University of Illinois Urbana-Champaign), Brian J. Stevenson(SIB Swiss Institute of Bioinformatics), Stylianos E. Antonarakis(University of Geneva)
Cited by 399
Abstract
Related Papers
MEK1 mutations confer resistance to MEK and B-RAF inhibition
Caroline M. Emery, Krishna G. Vijayendran, Marie Zipser et al.|Proceedings of the National Academy of Sciences|2009|634
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4
NISC Comparative Sequencing Program, Todd D. Prickett, Neena Agrawal et al.|Nature Genetics|2009|351